InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd. furnished this Form 6-K on August 14, 2023, reporting actions taken at a Special General Meeting of Shareholders and changes to the company’s stock exchange listings. The filing header states “For the Month of August 2022,” which appears inconsistent with the filing date and described events.
Key Financial Metrics
The filing does not provide financial statements or clear information on revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Shareholders approved a proposal at the company’s Special General Meeting in accordance with the required voting threshold. The filing does not restate the substance of the proposal; it refers readers to the July 10, 2023 notice.
- The last trading day of InterCure’s ordinary shares on the Toronto Stock Exchange was August 14, 2023, following approval of the company’s delisting request.
- The ordinary shares continue to trade on the Nasdaq Capital Market and the Tel Aviv Stock Exchange under the symbol “INCR.”
- The company will continue its U.S. SEC and Nasdaq reporting obligations and Israeli reporting obligations under the applicable Israeli securities-law framework, using the Nasdaq reporting regime in lieu of the TSX regime.
Outlook, Risks, and Unusual Items
No financial guidance, operating outlook, management forecast, material risks, contingencies, or unusual financial items are disclosed in the provided filing text. The TSX delisting does not affect the company’s continued Nasdaq or TASE listings.
Investor Verification Points
- Verify the substance and implementation status of the shareholder-approved proposal in the referenced July 10, 2023 meeting notice.
- Confirm the effective completion of the TSX delisting and the continued Nasdaq and TASE listing status.
- Review subsequent SEC and Israeli disclosures for any changes in reporting obligations, liquidity, operations, or capital structure.
- Confirm the filing period, because the header’s August 2022 designation conflicts with the August 14, 2023 filing date and events.